Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index |  Total Docs. (2009) |
Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Retrovirology | journal | 1.835 Q1 | 98 | 700 | 314 | 6726 | 1250 | 287 | 3.89 | 9.61 |  |
| 2 | Journal of General Virology | journal | 1.662 Q1 | 187 | 348 | 1180 | 14934 | 4350 | 1180 | 3.58 | 42.91 | |
| 3 | Virology Journal | journal | 1.004 Q2 | 99 | 229 | 404 | 8690 | 989 | 403 | 2.41 | 37.95 | |
| 4 | Cellular Microbiology | journal | 3.697 Q1 | 157 | 141 | 619 | 8166 | 3959 | 617 | 6.15 | 57.91 | |
| 5 | Expert Review of Anti-Infective Therapy | journal | 0.953 Q2 | 96 | 111 | 269 | 8438 | 735 | 239 | 2.95 | 76.02 | |
| 6 | Journal of Viral Hepatitis | journal | 1.376 Q1 | 110 | 110 | 384 | 4164 | 1455 | 370 | 3.75 | 37.85 | |
| 7 | Trends in Microbiology | journal | 4.006 Q1 | 231 | 78 | 264 | 4765 | 1953 | 248 | 7.39 | 61.09 | |
| 8 | Future Virology | journal | 0.307 Q3 | 45 | 64 | 113 | 3776 | 73 | 94 | 0.65 | 59.00 | |
| 9 | HIV Therapy | journal | 14 | 60 | 0 | 3725 | 0 | 0 | 0.00 | 62.08 | | |
| 10 | Journal of NeuroVirology | journal | 0.982 Q2 | 95 | 52 | 193 | 2011 | 486 | 186 | 2.24 | 38.67 | |
| 11 | African Journal of AIDS Research | journal | 0.284 Q3 | 34 | 51 | 105 | 2329 | 89 | 104 | 0.74 | 45.67 | |
| 12 | AIDS Research and Therapy | journal | 1.112 Q2 | 49 | 30 | 82 | 891 | 210 | 82 | 2.81 | 29.70 | |
| 13 | Reviews in Medical Virology | journal | 3.212 Q1 | 106 | 30 | 90 | 2683 | 652 | 71 | 6.93 | 89.43 | |
| 14 | Antiviral Chemistry and Chemotherapy | journal | 0.530 Q3 | 59 | 17 | 79 | 891 | 154 | 77 | 2.12 | 52.41 | |
| 15 | Journal of HIV Therapy | journal | 0.256 Q3 | 18 | 13 | 69 | 782 | 42 | 58 | 0.63 | 60.15 | |
| 16 | Gut Pathogens | journal | 56 | 7 | 0 | 233 | 0 | 0 | 0.00 | 33.29 | | |
| 17 | Journal of Viral Entry | journal | 2 | 5 | 0 | 251 | 0 | 0 | 0.00 | 50.20 | | |
| 18 | Advances in Antiviral Drug Design | book series | 0.523 Q3 | 12 | 0 | 7 | 0 | 14 | 6 | 2.00 | 0.00 | |
| 19 | Future HIV Therapy | journal | 0.191 Q4 | 8 | 0 | 57 | 0 | 20 | 46 | 0.35 | 0.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data